A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.
Qin
Wen
W
Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
Zhang
Rong
R
Hu
Cheng
C
Wang
Cong-rong
CR
Lu
Jing-yi
JY
Yu
Wei-hui
WH
Bao
Yu-qian
YQ
Xiang
Kun-san
KS
Jia
Wei-ping
WP
D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics*; D002219:Carbamates / Q000494:pharmacology / Q000627:therapeutic use*; D002681:China / Q000208:ethnology; D003924:Diabetes Mellitus, Type 2 / Q000208:ethnology / Q000235:genetics*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance / Q000208:ethnology / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D020641:Polymorphism, Single Nucleotide
D048868:Adaptor Proteins, Signal Transducing; D002219:Carbamates; D007004:Hypoglycemic Agents; C488081:NOS1AP protein, human; D010880:Piperidines; C072379:repaglinide